We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




New Technique for Switching Off Genes

By Biotechdaily staff writers
Posted on 17 Jul 2002
A method has been developed to inactivate selected genes in mice through RNA inhibition. More...
The technique involves injecting mice with DNA that produces an unusual folded RNA in a single, double-stranded molecule. The research was reported in the July 4, 2002, issue of Nature.

"RNA inhibition has been shown to work in lower organisms, but there was some question about whether it would work in mammals,” said Dr. Mark Kay, professor of genetics and pediatrics at Stanford University (Palo Alto, CA, USA) and one of the researchers.

The main problem with RNA inhibition is the rapid rate at which cells destroy injected double-stranded RNA. A more promising approach is to inject suitable DNA, which would continually produce the proper RNA. Usual methods of injecting DNA, however, produce single-stranded RNA, which is useless for inhibition.

Using a type of DNA that produces an unusual form of RNA, which doubles back on itself like a hairpin to make a single, double-stranded molecule, solved the problem. Injecting this DNA into mice resulted in the production of single-stranded, folded RNA that was as effective at inhibiting the target gene as injecting double-stranded RNA. Furthermore, even after the hairpin RNA breaks down, the DNA remains in the cell and continues producing new RNA.

Dr. Kay stated that this initial work is a proof of concept. "The ultimate goal is to use this to treat a disease. We can do this by placing these molecules into standard gene-therapy vectors.”



Related Links:
Stanford Univesity

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.